Drug: Bevacizumab Injury: Dyspnoea Quarter: 2016Q3
Total Records: 33 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 81331126 | Bevacizumab | Dyspnoea | ROCHE | 0.00 | F | 0 | 20160912 | US |
| 81879102 | Bevacizumab | Dyspnoea | ROCHE | 68.00 YR | M | 81 KG | 20160915 | US |
| 82298324 | Bevacizumab | Dyspnoea | ROCHE | 76.99 YR | F | 0 | 20160712 | FR |
| 86818712 | Bevacizumab | Dyspnoea | ROCHE | 74.84 YR | M | 85 KG | 20160914 | US |
| 95804078 | Bevacizumab | Dyspnoea | ROCHE | 78.80 YR | M | 70 KG | 20160818 | GB |
| 97780392 | Bevacizumab | Dyspnoea | ROCHE | 62.00 YR | F | 65 KG | 20160929 | US |
| 98242087 | Bevacizumab | Dyspnoea | ROCHE | 62.00 YR | M | 107 KG | 20160909 | DE |
| 101489614 | Bevacizumab | Dyspnoea | ROCHE | 70.00 YR | F | 56 KG | 20160919 | US |
| 123686475 | BEVACIZUMAB | Dyspnoea | MERCK | 8.00 YR | F | 0 | 20160712 | US |
| 123714732 | Bevacizumab | Dyspnoea | ROCHE | 62.00 YR | M | 73 KG | 20160906 | US |
| 125515431 | Bevacizumab | Dyspnoea | CIPLA | 0.00 | 0 | 20160713 | US | |
| 125515491 | Bevacizumab | Dyspnoea | CIPLA | 0.00 | 0 | 20160713 | US | |
| 125551191 | Bevacizumab | Dyspnoea | ROCHE | 49.00 YR | F | 50 KG | 20160714 | DE |
| 125606931 | Bevacizumab | Dyspnoea | CIPLA | 0.00 | 0 | 20160715 | DE | |
| 125653661 | Bevacizumab | Dyspnoea | CELGENE | 0.00 | 0 | 20160718 | US | |
| 126009073 | Bevacizumab | Dyspnoea | ROCHE | 0.00 | 0 | 20160901 | US | |
| 126128551 | Bevacizumab | Dyspnoea | ROCHE | 0.00 | 0 | 20160802 | US | |
| 126251631 | BEVACIZUMAB | Dyspnoea | JANSSEN | 0.00 | F | 0 | 20160805 | US |
| 126267892 | BEVACIZUMAB | Dyspnoea | AMGEN | 0.00 | F | 0 | 20160812 | US |
| 126586681 | Bevacizumab | Dyspnoea | ROCHE | 78.00 YR | M | 0 | 20160817 | DE |
Total Records: 33 Number of Pages: 2